IRIDEX Corp
IRIX
查看詳細走勢圖
1.000USD
+0.030+3.09%
收盤 12/19, 16:00（美東）報價延遲15分鐘
17.05M總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
+3.09%
5天
+8.60%
1月
+6.38%
6月
+7.18%
今年開始到現在
-40.48%
1年
-39.02%
查看詳細走勢圖
TradingKey IRIDEX Corp股票評分
單位: USD 更新時間: 2025-12-19操作建議
IRIDEX Corp當前公司基本面數據相對健康，增長潛力較大。當前估值合理，在醫療設備與耗材行業排名150/208位。機構持股佔比非常高，中期看，股價處於平穩狀態。近一個月，市場表現較強，技術面和基本面綜合得分較高，較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間，可以做區間波段操作。
IRIDEX Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
0
分析師
--
評級
--
目標均價
--
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
IRIDEX Corp亮點
亮點風險
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
業績增長期
公司處於發展階段，最新年度總收入48.67M美元
利潤高增長
公司淨利潤處於行業前列，最新年度總收入48.67M美元
估值合理
公司最新PE估值-3.32，處於3年歷史合理位
機構減倉
最新機構持股2.61M股，環比減少16.95%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉，最新持倉389.06K股
活躍度降低
近期活躍度降低，過去20天平均換手率0.39
IRIDEX Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
IRIDEX Corp簡介
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
公司代碼IRIX
公司IRIDEX Corp
CEOMercer (Patrick)
網址https://www.iridex.com/
常見問題
IRIDEX Corp(IRIX)的當前股價是多少？
IRIDEX Corp(IRIX)的當前股價是 1.000。
IRIDEX Corp 的股票代碼是什麼？
IRIDEX Corp的股票代碼是IRIX。
IRIDEX Corp股票的52週最高點是多少？
IRIDEX Corp股票的52週最高點是1.890。
IRIDEX Corp股票的52週最低點是多少？
IRIDEX Corp股票的52週最低點是0.782。
IRIDEX Corp的市值是多少？
IRIDEX Corp的市值是17.05M。
IRIDEX Corp的淨利潤是多少？
IRIDEX Corp的淨利潤為-8.91M。
現在IRIDEX Corp(IRIX)的股票是買入、持有還是賣出？
根據分析師評級，IRIDEX Corp(IRIX)的總體評級為--，目標價格為--。
IRIDEX Corp(IRIX)股票的每股收益（EPS TTM）是多少
IRIDEX Corp(IRIX)股票的每股收益（EPS TTM）是-0.301。
相關品種
-0.24%
+0.25%
+0.87%
+1.88%
+0.22%
-0.55%
+0.53%
+0.12%
+1.35%
-0.10%
-1.23%
-0.77%
+0.10%
+0.46%
+0.46%
+0.97%
+0.59%
+0.23%
+0.45%
+1.74%
